Ohr Pharmaceutical, Inc. (OHRP) will report its next earnings on Dec 21 AMC. The company reported the earnings of $-0.08/Share in the last quarter where the estimated EPS by analysts was $-0.08/share.
Many analysts are providing their Estimated Earnings analysis for Ohr Pharmaceutical, Inc. and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.07/share. These analysts have also projected a Low Estimate of $-0.07/share and a High Estimate of $-0.07/share.
Some buy side analysts are also providing their Analysis on Ohr Pharmaceutical, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Ohr Pharmaceutical, Inc. might touch $0.4 high while the Average Price Target and Low price Target is $0.4 and $0.4 respectively.
The Relative Volume of the company is 2.64 and Average Volume (3 months) is 2.27 million.
The company shows its Return on Assets (ROA) value of -81.4%. The Return on Equity (ROE) value stands at -100%.
While looking at the Stock’s Performance, Ohr Pharmaceutical, Inc. currently shows a Weekly Performance of -84.12%, where Monthly Performance is -79.18%, Quarterly performance is -54.22%, 6 Months performance is -49.1% and yearly performance percentage is -78.62%. Year to Date performance value (YTD perf) value is -82.76%. The Stock currently has a Weekly Volatility of 18.81% and Monthly Volatility of 12.51%.